References
- EQ-5D-5L – EQ-5D. Euroqol. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/. Accessed 623, 2017.
- GusiN, OlivaresPR, RajendramR. The EQ-5D health-related quality of life questionnaire In: PreedyVR, WatsonRR, editors. Handbook of Disease Burdens and Quality of Life Measures. New York: Springer; 2010: 87–99. Available from:http://link.springer.com/referenceworkentry/10.1007/978-0-387-78665-0_5. Accessed 623, 2017.
- Guide to the methods of technology appraisal 2013. Guidance and guidelines | NICE. Available from: https://www.nice.org.uk/process/pmg9/chapter/foreword. Accessed 11 9, 2018.
- NolanCM, LongworthL, LordJ, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500. doi:10.1136/thoraxjnl-2015-20778227030578
- StarkieHJ, BriggsAH, ChambersMG, JonesP. Predicting EQ-5D values using the SGRQ. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2011;14(2):354–360. doi:10.1016/j.jval.2010.09.011
- DesléeG, MalH, DutauH, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA. 2016;315(2):175–184. doi:10.1001/jama.2015.1782126757466
- DesleeG, BarbeC, BourdinA, et al. Cost-effectiveness of lung volume reduction coil treatment in emphysema. STIC REVOLENS. Rev Mal Respir. 2012;29(9):1157–1164. doi:10.1016/j.rmr.2012.09.01023200592
- BulseiJ, LeroyS, PerotinJ-M, et al. Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study). Respir Res. 2018;19(1):84. doi:10.1186/s12931-018-0796-x29743071
- St. George’s Respiratory Questionnaire – Health Status Research Team. Available from: http://www.healthstatus.sgul.ac.uk/sgrq. Accessed 626, 2017.
- MolkenMR, RoosB, Van NoordJA. An empirical comparison of the St George’s Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax. 1999;54(11):995–1003. doi:10.1136/thx.54.11.99510525558
- WilkeS, JanssenDJ, WoutersEF, ScholsJM, FranssenFM, SpruitMA. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study. Health Qual Life Outcomes. 2012;10:98. doi:10.1186/1477-7525-10-9822909154
- PickardAS, YangY, LeeTA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:26. doi:10.1186/1477-7525-9-2621501522
- JuniperE, GuyattG, JaeschkeR. How to develop and validate a new health-related quality of life instrument In: Quality of Life and Pharmacoeconomics in Clinical Trials. 2 ed. Philadelphia: Spilker Bert; 1996:49–56.
- LinLI-K. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45(1):255–268. doi:10.2307/25320512720055
- BlandJM, AltmanDG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–160. doi:10.1177/09622802990080020410501650
- BiswasM, ChattopadhyayK. Relationship between health-related quality of life and respiratory health status among coal-based sponge iron plant workers in Barjora, India. Z Gesundheitswissenschaften. 2018;26(3):355–359. doi:10.1007/s10389-017-0861-9